title: The use of nebulised aztreonam lysine (AZLI) in aztreonam hypersensitive patients.
authors.forename: P
authors.initials: P
authors.lastname: Whitaker
authors.forename: C
authors.initials: C
authors.lastname: Etherington
authors.forename: K
authors.initials: K
authors.lastname: Williams
authors.forename: S
authors.initials: S
authors.lastname: Conway
authors.forename: D
authors.initials: D
authors.lastname: Peckham
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects; D001398:Aztreonam / Q000008:administration & dosage* / Q000009:adverse effects*; D003550:Cystic Fibrosis / Q000382:microbiology*; D004342:Drug Hypersensitivity / Q000517:prevention & control*; D006801:Humans; D009330:Nebulizers and Vaporizers; D011552:Pseudomonas Infections / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D001398:Aztreonam